187 related articles for article (PubMed ID: 2435809)
1. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
Iida K; Mitomo K; Fujita T; Tamura N
J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
3. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
Thornton BP; Vetvicka V; Ross GD
Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
Garred P; Mollnes TE; Lea T; Fischer E
Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
[TBL] [Abstract][Full Text] [Related]
5. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
6. Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.
Halkjær L; Troldborg A; Pedersen H; Jensen L; Hansen AG; Hansen TK; Bjerre M; Østergaard JA; Thiel S
Front Immunol; 2020; 11():774. PubMed ID: 32431705
[TBL] [Abstract][Full Text] [Related]
7. C3b binding immune complexes and immunoconglutinins in human sera. Detection by enzyme-linked immunosorbent assay (ELISA).
Hautanen A; Linder E
J Immunol Methods; 1979; 30(4):367-80. PubMed ID: 512366
[TBL] [Abstract][Full Text] [Related]
8. Enzyme immunoassay detection of circulating immune complexes by monoclonal antibodies to C3 neoepitopes with special reference to IgG concentration and to interfering anti-immunoglobulin antibodies.
Garred P; Mollnes TE; Lea T; Lachmann PJ
J Immunol Methods; 1989 Feb; 117(1):59-66. PubMed ID: 2464039
[TBL] [Abstract][Full Text] [Related]
9. The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.
Troldborg A; Jensen L; Deleuran B; Stengaard-Pedersen K; Thiel S; Jensenius JC
Front Immunol; 2018; 9():581. PubMed ID: 29632534
[TBL] [Abstract][Full Text] [Related]
10. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
11. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
[TBL] [Abstract][Full Text] [Related]
12. Quantitative immunoassay for IgA class circulating immune complexes using solid phase Facb fragment of anti-C3.
Hosoda K; Sakurabayashi I; Kawai T; Suzuki H; Maeda M; Tsuji A
J Immunol Methods; 1985 Oct; 82(2):243-52. PubMed ID: 3900216
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course.
Nilsson B; Ekdahl KN; Sjöholm A; Nilsson UR; Sturfelt G
Clin Exp Immunol; 1992 Nov; 90(2):251-5. PubMed ID: 1424282
[TBL] [Abstract][Full Text] [Related]
14. Activated C3 (C3b) in the nephritic glomerulus.
Pan C; Strife CF; McAdams AJ; West CD
Pediatr Nephrol; 1993 Aug; 7(4):379-86. PubMed ID: 8398646
[TBL] [Abstract][Full Text] [Related]
15. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
[TBL] [Abstract][Full Text] [Related]
16. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
17. Studies on circulating immune complexes. III: Kinetics of the immunoglobulin class of circulating immune complexes in systemic lupus erythematosus.
Miura Y
Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):201-9. PubMed ID: 2739119
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2019; 10():64. PubMed ID: 30761135
[TBL] [Abstract][Full Text] [Related]
19. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
Yokoyama I; Waxman F
Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
[TBL] [Abstract][Full Text] [Related]
20. Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments.
Nilsson B; Svensson KE; Borwell P; Nilsson UR
Mol Immunol; 1987 May; 24(5):487-94. PubMed ID: 2443836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
